Small Plastic Medicine Drug Bag/Zip Lock Pill Bag

Name: Small Plastic Medicine Drug Bag/Zip Lock Pill Bag
Brand: Shijiazhuang G-House Trading Co., Ltd.
SKU: 2020453942

Hebei, ChinaShijiazhuang G-House Trading Co., Ltd.

US$0.002-0.01

200,000 Pieces

Sample price:US$0.20/bag.Request sample

Product profile

Customization

Available

Closure Type

Ziplock Bag

Color

White

Model NO.

90*70mm*0.03mm

Material

LDPE, Polyethylene

Recycled

Unrecycled

Size

Extra-large

Special Features

Child-resistant, Moisture-resistant

Thickness

0.2 mm

Usage

Herbal medicine packaging, Liquid medication packaging, Pharmaceutical packaging, Pill packaging, Powder packaging, Pharmacy

Application

Medical

Logo Printing

with Logo Printing

Flexibility

Soft

Type

Seal Bag

Bag Variety

Zipper Top

Size Range

3*4cm to 50cm*65cm

Thickness Range

25mic to 150mic for Single Side

Transport Package

Export Carton Box

Specification

90*70mm*0.3mm

Trademark

OEM

Origin

China

HS Code

3923210000

Production Capacity

300 Tons / Month

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceFast Delivery

Shijiazhuang G-House Trading Co., Ltd.

Hebei, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2008-08-13Nearest Port: Xingang, Qingdao, ShanghaiAverage Response Time: ≤7.28hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF

AI-Powered supplier vetting

SummaryShijiazhuang G-House Trading Co., Ltd. is a Chinese limited trading company primarily engaged in pharmaceuticals. Despite strong export activity and considerable customization capability, the company lacks certain service capabilities and comprehensive after-sales procedures. The firm provides OEM and ODM services but doesn't have a significant R&D focus or SDK availability. Financial data is available for the past three years, but overseas presence is limited.

Supplier typeThe supplier is identified as a limited company with a trading and manufacturing role, focusing on pharmaceuticals.

CertificationsThe supplier was audited by BV, but the result of the evaluation wasn't favorable, as indicated by the audit result '0'.

After-Sales capabilityThere are no written procedures or records for handling corrective actions or customer complaints, indicating a lack of systematic after-sales service capability.

Financial creditFinancial data is recorded for the past three years (2020, 2021, 2022), which suggests a level of financial transparency.

R&D capabilityThe supplier lacks innovation indicators like R&D with SDK availability and hasn't developed new products in the past year.

Production capacityThe supplier offers OEM and ODM services, indicating strong production capabilities in terms of design and manufacturing.

Customization capabilityThere is significant customization capability, with services ranging from minor to full customization.

Client casesThe supplier lacks overseas showrooms, agents, or branches and hasn't participated in offline trade shows, suggesting limited customer engagement globally.